Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Aceragen Inc reported $4K in Ordinary Share Capital for its fiscal quarter ending in December of 2022.

Ordinary Share Capital Change
Abbott ABT:US USD 24.49B 221M
Aceragen Inc IDRA:US USD 4K 55K
Agenus AGEN:US USD 3.42M 361K
Alnylam Pharmaceuticals ALNY:US USD 1.24M 3K
BioMarin Pharmaceutical BMRN:US USD 188K 2K
Dynavax Technologies DVAX:US USD 128K 0
Eli Lilly LLY:US USD 593.5M 600K
GlaxoSmithKline GSK:LN GBP 1.35B 1000K
Mirati Therapeutics MRTX:US USD 58K 0
Nektar Therapeutics NKTR:US USD 19K 0
Roche Holding ROG:VX CHF 107M 0
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 187K 0
Ultragenyx Pharmaceutical RARE:US USD 71K 1000